Previous Article | Next Article ![]()
Infect. Immun., 07 1997, 2587-2592, Vol 65, No. 7
JM Pollock and P Andersen
Tuberculosis continues to be a worldwide health problem for both humans and
animals. The development of improved vaccines and diagnostic tests requires
detailed understanding of the immune responses generated and the antigens
recognized during the disease. This study examined the T- cell response
which develops in cattle experimentally infected with Mycobacterium bovis.
The first significant T-cell response was found 3 weeks after the onset of
infection and was characterized by a pronounced gamma interferon
(IFN-gamma) response from peripheral blood mononuclear cells directed to
antigens in culture filtrates. Short-term culture filtrate (ST-CF) was
separated into molecular mass fractions and screened for recognition by T
cells from experimentally infected and field cases of bovine tuberculosis.
Cattle in the early stages of experimental infection were characterized by
strong IFN-gamma responses directed predominantly toward the lowest-mass
(<10-kDa) fraction of ST- CF, but cattle in later stages of experimental
infection (16 weeks postinfection) exhibited a broader recognition of
antigens of various molecular masses. Field cases of bovine tuberculosis,
in comparison, preferentially recognized low-mass antigens, characteristic
of animals in the early stages of infection. The major T-cell target for
this dominant IFN-gamma response was found to be the secreted antigen ESAT-
6. This antigen was recognized strongly by the majority of field cases of
bovine tuberculosis tested. As ESAT-6 is unique to pathogenic mycobacterial
species, our study suggests that ESAT-6 is an antigen with major potential
for vaccination against and specific diagnosis of bovine tuberculosis.
Copyright © 1997, American Society for Microbiology
Predominant recognition of the ESAT-6 protein in the first phase of interferon with Mycobacterium bovis in cattle
Department of Agriculture for Northern Ireland, Stormont, Belfast, United Kingdom.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|